BioSpace News Archive

Inspira™ Technologies OXY B.H.N. Ltd. announced today that the Israeli Patent Office (ILPO) granted a patent for a key safety component of the INSPIRA TM ART system.

RespireRx Pharmaceuticals Inc. is pleased to announce that Jeff Margolis, Senior Vice President, Chief Financial Officer, Treasurer and Secretary is presenting a summary and update about the Company at the Investor Summit Q4 sponsored by the Investor Summit Group (https://investorsummitgroup.com), in person, on November 14, 2022 from 2:00-2:30pm EST at the Sheraton Times Square, New York, NY.

The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced awards and funding for projects focused on improving quality of patient care and outcomes for locally advanced or metastatic bladder cancer.

Lytix Biopharma AS today announces the release of new data describing how LTX-315 treatment activates specific immune cells that are critical for a proper priming of tumor-specific T cells.

Medicenna Therapeutics Corp. today announced new safety, pharmacokinetic (PK), and pharmacodynamic (PD) data from the first four dose escalation cohorts of the Phase 1/2 ABILITY study of MDNA11, the Company’s “beta-only” long-acting IL-2 super-agonist.

Codiak BioSciences, Inc. today announced new preclinical data from its exoASO™-STAT6 and exoASO™-C/EBPβ programs.

Allakos Inc. inflammatory and proliferative diseases, today announced a poster presentation at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting.

Allogene Therapeutics, Inc. today presented pre-clinical data on a novel approach to immune “cloaking” designed to protect AlloCAR T™ cells from rapid host rejection.

Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today announced updated overall survival (OS) results from its Phase 1/2 study evaluating GRANITE, an individualized vaccine-based immunotherapy, for the treatment of advanced solid tumors.

PepGen Inc. reported financial results for the third quarter ended September 30, 2022 and highlighted recent corporate developments.